FIZZ Heads Into Earnings Down 16% With Bears Firmly in Charge

The short-side conviction is real but not extreme. Short interest has climbed 13% over the past week and 15.5% over the past month, reaching 3.8% of the free float — meaningful for a company this thinly followed, and a consistent upward trend since early June. The ORTEX short score of 64 places FIZZ in elevated territory relative to the broader market, though the borrow cost of 0.50% remains low, suggesting shorts are comfortable holding rather than squeezed. The picture is of a measured, steady build in bearish positioning rather than a panic-driven pile-on.

The analyst story is simple and one-directional. UBS is the only covering firm and has held a Sell rating for years, trimming its target to $33 from $35 just last week — the latest in a long series of downward revisions that have taken the target from $48 in mid-2024 to where it stands now. With the stock at $31 and the target at $33, the Sell-rated consensus implies almost no upside. The bear case centres on continued weakness in carbonated soft drink demand and a failure to capitalise on healthier beverage trends, themes that recent notes identify as persistent rather than cyclical. Bulls, to the extent they exist outside the concentrated insider ownership base — IBS Partners, the Caporella family vehicle, controls 71% of shares — would point to solid underlying fundamentals: a Piotroski F-Score of 6, an ROA near 21%, and the possibility that any positive earnings surprise would be amplified by thin float and modest short covering.

The print therefore tests whether National Beverage can offer any evidence of volume stabilisation or margin resilience sufficient to push back against a year-long analyst de-rating and a month of accelerating price declines.